![]() |
|
|
4 UMR U557 INSERM, U1125 INRA and Paris 13 University, CNAM, Centre de Recherche en Nutrition Humaine-IdF, 93017 Bobigny, France and 5 Unité de Surveillance et d'Epidémiologie Nutritionnelle, Institut de Veille Sanitaire; PARIS 13 University, CNAM, Centre de Recherche en Nutrition Humaine-IdF, 93017 Bobigny, France and 6 Département de Santé Publique, Hôpital Avicenne, 93017 Bobigny, France
* To whom correspondence should be addressed. E-mail: c.estaquio{at}uren.smbh.univ-paris13.fr.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Recently, dietary patterns have been developed by using a priori methods (4–6). Greater adherence to healthy dietary patterns has been associated with lower mortality (7–9) and a lower incidence of CVD in various populations (10–13). Whereas most indexes are based on food groups (and some include nutrients), one published index score included both dietary (groups of foods and nutrients) and nondietary components [physical activity (PA) and BMI] (14) and found a significantly reduced risk of cancer in postmenopausal women.
In France in 2001, the French National Nutrition and Health Program [Program National Nutrition Santé (PNNS)] was implemented under the aegis of the Ministry of Health. Its general goal is to improve the health status in the general population by intervening at the level of one of its determinants, nutrition (15). Among the 9 nutritional goals targeted for the 2001–10 period, 5 are related to diet [fruits and vegetables (F&V), calcium and vitamin D, lipids, carbohydrate and fibers, and alcohol intake), 1 concerns PA in daily life, and 3 involve nutritional markers (serum cholesterol, BP, and BMI). Whereas some national surveys are being conducted to describe the nutritional situation according to PNNS indicators, this is also worth evaluating the possible benefit in prevention of chronic diseases.
We have developed an index score that includes all indicators used to define PNNS objectives. The aim of our study was to examine the relationship between this score and the incidence of major chronic diseases in a cohort of French adults.
| Materials and Methods |
|---|
|
|
|---|
The design, methods, and rationale of the Supplémentation en Vitamines et Minéraux Antioxydants (SU.VI.MAX) study have been described elsewhere (16). Briefly, the SU.VI.MAX study was initially designed as a randomized, double-blind, placebo-controlled, primary prevention trial to test the efficacy of daily supplementation with antioxidant vitamins and minerals at nutritional doses [120 mg of ascorbic acid, 30 mg of vitamin E (
-tocopherol), 6 mg of β-carotene, 100 µg of selenium, and 20 mg of zinc] in reducing the incidence of ischemic heart diseases and cancer. Women were 35–60 y of age and men were 45–60 y of age at enrollment. The lower age in women was based on the incidence of breast and uterine cancers and ischemic CVD (16). The SU.VI.MAX study was approved by the Ethical Committee for Studies with Human Subjects at Paris-Cochin Hospital and the Commission Nationale Informatique et Liberté. Throughout the study, respondents completed dietary records and health and demographic questionnaires, provided blood samples, and underwent physical examinations.
Subjects who completed at least 3 24-h dietary records during the first 24 mo of follow-up, were free of cancer or ischemic CVD during that period, and had no missing covariables were included in the present analyses.
Data collection
Information on gender, age, smoking habits, education level, occupation, and marital status was collected by a self-administrated questionnaire at enrollment. Each subject underwent a yearly visit involving either biochemical sampling (at y 0, 2, 5, and 7) or clinical examination (at y 1, 3, and 7).
Dietary assessment
Subjects were asked to provide 24-h dietary records every 2 mo for a total of 6 records per year; each day of the week and all seasons were represented (16). Participants used a validated reference manual for coding food portions (17). Nutrient intakes, including vitamins, minerals, and alcohol, were estimated using food composition tables validated for the usual French foods (18).
Assessment of PA
PA was assessed using the French self-administered version of the Modifiable Activity Questionnaire (19). Briefly, information was collected about the type, frequency, and duration of activity performed. Using published compendiums (20,21), metabolic equivalent tasks were assigned to each leisure activity reported and summary scores were computed, including the mean metabolic equivalent task-hours per week of PA.
Blood sampling
At baseline, a 35-mL venous blood sample was obtained from participants who had been fasting for 12 h. Some nutritional biomarkers were measured (22).
Clinical examination
Height, weight, and BP were measured at each clinical examination. Weight was measured using an electronic scale with subjects wearing indoor clothing and no shoes. Height was measured under the same conditions to the nearest 0.5 cm using a wall-mounted stadiometer. BMI was calculated as weight (kg) divided by height-squared (m2). BP was measured using a standardized procedure with a mercury sphygmomanometer. It was taken once from each arm in subjects who had been lying down for 10 min. The mean of these 2 measurements was used for analyses. If systolic BP (SBP) was
160 mm Hg or diastolic BP
110 mm Hg, BP was remeasured after another rest period of 10 min and the lowest value was retained.
Follow-up of major chronic diseases
Participants were asked to complete a monthly questionnaire summarizing treatment compliance and health events. Information about health outcomes was obtained from subjects' reports and from data collected at yearly visits. If there was no contact with a participant for a long period or if a participant did not attend the yearly scheduled visit, an investigation was launched to determine the reasons. Once an adverse event was suspected, all relevant records, including results of diagnostic tests and procedures (imaging, biopsy, etc.) were collected from physicians and hospitals involved or directly from participants. Each event was reviewed by expert committees who did not know the supplementation assignment. Cancers were validated by histologic reports; ischemic CVD were confirmed by radiologic reports or by meeting a combination of clinical, biological, and electrocardiographic criteria when appropriate. Causes of death were confirmed by information from relatives or physicians. Vital status of all subjects and causes of death were verified with the national death registry.
Construction of the French score of indicators of PNNS objectives
Indicator definition. Construction of the French score of indicators of the PNNS objectives (FSIPO) was primarily based on indicators used to define the 9 priority PNNS public health objectives (Supplemental Table 1). A "healthy" threshold was identified for each indicator using the statement of the objective itself or an external reference like the French national recommended dietary allowances (RDA) (23) or distribution observed within the SU.VI.MAX study. For instance, the indicator concerning the F&V group was defined according to the PNNS definition of "low consumers" i.e. <3.5 servings per day (24). The indicator was therefore the intake of F&V around this threshold. The next step was to identify foods included in the F&V group. According to detailed information provided in PNNS dietary guidelines, this group includes all fruits (excluding dried fruits), vegetables (excluding potatoes and legumes), 100% juices, and mixed foods containing F&V. French recipes validated by dieticians were used to assess amounts consumed from mixed foods. The number of servings was defined as total weight of F&V (g/d) divided by a standard serving size, i.e. 80 g. Thresholds for indicators of calcium, fibers, and simple carbohydrates were defined according to the French RDA (23). Thresholds for BP and cholesterol components were defined by means observed in the SU.VI.MAX study. The intake of simple sugars was assessed by the contribution of total simple sugars to total energy intake (EI; excluding alcohol) with respect to the French RDA (23). The same approach was used for assessing consumption of complex carbohydrates. Because only a subsample of subjects had available vitamin D status measurements, it was not included in the component corresponding to the calcium and vitamin D objective.
Index scoring. Scoring decisions were made a priori and based on the national program objectives (Supplemental Table 1) or epidemiological or clinical evidence (1–3) that had been evaluated by a task group, which included nutrition researchers, epidemiologists, statisticians, and dieticians.
The general approach (Table 1) consisted of attributing 1 point (maximum score) to subjects who reached the PNNS indicator threshold, with the exception of PA, for which an additional one-half point was given to subjects who exceeded current guidelines. For each component, intermediate points (0.5 points) were attributed to those who did not entirely attain the threshold but whose nutritional status was considered "fair." The rest of the subjects did not receive any point. PNNS priority objectives are not ranked according to their public health importance. The task group chose to apply a weighing scheme to capture specific dietary patterns and nutritional status indicators that have been consistently associated with lower risks of chronic disease (Table 1). A priori weightings and internal weightings were chosen on this basis.
|
In total, the FSIPO consisted of 13 components based on indicators of the 9 priority objectives described in the PNNS. The overall FSIPO ranged from 0 to 17.5 points; higher scores reflected dietary patterns that approached indicators used for defining national objectives.
Statistical analyses
Statistical analyses were performed by gender to account for the study design. The mean of all 24-h dietary records assessed during the recording period was used in the analyses. Some serum or plasma nutrient concentrations were log-transformed to improve normality. We used ANOVA to investigate the relationship between the FSIPO tertile distribution and demographic and socioeconomic status. Multivariate linear regression models controlled for age (continuous) and total EI (continuous) were used to examine associations of nutrient intake or biomarkers to the FSIPO and included a linear contrast to test for trend. We analyzed relationships between the FSIPO and major chronic disease events by survival analyses. Follow-up time was the time between the end of the first 2 y of follow-up (1996–97) and the first CVD or cancer event, death, last contact, or the day the subject completed a total of 10 y of follow-up (2004–05). Initially, the design of the study defined primary outcomes as major fatal and nonfatal ischemic CVD [International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes 120–125, 163, 165, 166, 170, 171, 174] and cancer of any kind (ICD-10-CM codes C00-C97, D00-D09, D37-D48), except for basal cell carcinoma of the skin (ICD-10-CM codes C44 and M809-M811) (27). A secondary outcome was all-cause mortality. In our study, the primary endpoint was a major chronic disease event defined as combination of CVD, cancer, or death, whichever came first. Hazard ratios (HR) and their 95% CI were estimated using Cox proportional hazards models (28). All Cox models were adjusted for age (continuous). Models were controlled for smoking status (never, former, current), education level (primary school, secondary school, high school or equivalent), and total EI (continuous). In women, menopausal status (yes/no) and number of children (0, 1–2,
3) were also included. All Cox models included a linear contrast to test for trend. The multivariate-adjusted model also included daily supplementation (placebo, intervention group) to account for the study design. We verified that independent variables used in multivariate models were not colinear. Graphic methods and time-extended Cox models were used to check the proportional hazards assumption for this study. This assumption did not appear to be violated. Values in the text are means ± SD unless otherwise indicated. Differences were considered significant at P < 0.05. All analyses were performed using SAS software (SAS Institute, version 8.2).
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
A significant protective association has been observed in most studies that analyzed the relationship between diet-based indexes and total cardiovascular and cancer mortality, regardless of whether they included nutrient intakes (8,9,29) or not (7). For example, Kant et al. (9) found that the Recommended Food Score was associated with a decreased risk of cancer mortality. However, the Recommended Food Score was heavily weighted by the F&V component, which contributed 15 of a total of 23 points. Nevertheless, this result supports the demonstrated protective role of F&V against certain cancers.
Only a few studies have examined the relationship between dietary guidelines and the incidence of chronic diseases. Two cohort studies investigated the association between the incidence of CVD and cancer (10,11) and the Healthy Eating Index (HEI) (30). HEI had a moderate inverse association with major chronic diseases and with CVD in men after 8 y of follow-up (10). HEI and CVD were weakly associated in women who were followed over 12 y. No association with cancer incidence was found. Although the scores are not directly comparable due to their different components, our results follow the same trend.
Several hypotheses might explain the absence of an association between the FSIPO and major chronic disease events in women in our study. First, the most common female cancer occurring during the SU.VI.MAX follow-up was breast cancer. The relationship between diet and breast cancer remains inconclusive in the literature (31,32). However, associations between breast cancer in postmenopausal women and alcohol intake, weight gain in adulthood, and PA have recently been widely acknowledged (1–3). Small variations of these lifestyle factors were observed in our study except for PA; moreover, the low number of postmenopausal breast cancers and insufficient duration of follow-up could have led to insufficient statistical power. In our study, cases of cancer were 5.5 times as high as CVD occurrences in women, whereas in men, the number of cancer and CVD cases was similar. This probably had an incidence on differences in associations of the FSIPO with major chronic diseases.
In a study conducted among postmenopausal women (14) with nondietary components removed from the index, a nonsignificant effect on cancer incidence was observed. We did not find a significant effect on the incidence of major chronic diseases in men when the same approach was used (data not shown). The nutritional markers measured in our study might be viewed as intermediate factors in the relationship between diet and chronic disease occurrence. However, cholesterol level, BP, and body mass are probably insufficient to ensure protective effects. The combination of an adequate diet, nutritional markers, and PA may work synergistically to enhance chronic disease prevention.
The Dietary Guidelines for Americans Adherence Index (33) includes a penalty system as in our analyses. In France, the recommended number of servings per day is not adjusted for age, gender, or EI compared with the United States. However, excessive EI is of interest when analyzing diet quality (6,33). Our penalty approach had an impact on our results: mean EI were similar across tertiles when the deduction was applied in women, whereas this was not the case in men. However, the prognostic value of the FSIPO was no longer significant in men when the penalty was not applied, although men with or without penalty were ranked in the same fashion.
The exclusion of a large number of subjects limited the external validity of our results (34). Moreover, our study included subjects recruited on a voluntary basis (16) who may have been more interested in health and nutrition than the typical study participant. The choices made a priori regarding the points attributed to each indicator can be discussed. Such categories may conceal the true variability in intake data and reduce the range of scores (6). The FSIPO cut-off values (with 3 possible values) discriminate individuals according to their adherence to the guidelines (data not shown). Because PNNS guidelines were not disseminated at the time of the study, we used the FSIPO retrospectively in the SU.VI.MAX cohort. The FSIPO should now be applied to populations willing to comply with PNNS recommendations. Studies analyzing methods of diet description that fit with the score approaches should also be developed. The inaccurate estimation of portion sizes or underreporting of "unhealthy" food consumption are inherent with 24-h dietary records. We minimized these limitations by using at least 3 d of records.
Several strengths of our study should also be stressed. Higher FSIPO scores were related to both healthy lifestyle components (nonsmokers, normal BMI) and nutritional status (dietary and biochemical markers). The use of 3 24-h records during 2 y of follow-up enables a satisfactory dietary estimation, limits misclassification by decreasing intra-individual variation (35), and could be considered as more reliable and precise for assessing intakes compared with FFQ, which were used in previous studies (10,11,14). Diet was very stable over the study period in this cohort (data not shown) and these measures can be considered as representative of the usual diet. Finally, this score includes both dietary and biochemical markers measured using standardized procedures in a large population sample and many potentially confounding factors were included in the analyses.
The significant association between the FSIPO and nutrient intake and nutritional biomarkers could be taken as an intermediate validation of our approach. As expected, subjects with higher scores had better nutritional status, as assessed through biological markers. Although the associations were consistent in men and women, analyses were stratified on gender, because inclusion criterion related to age varied across gender in the SU.VI.MAX study. Moreover, gender-stratified analyses showed better diet and nutritional status in women than in men, resulting in a higher FSIPO score.
Age and healthy dietary habits were associated; older men had slightly better mean scores than middle-aged men. This result is consistent with the literature (30,33,36). For women, however, the younger women had better scores, which could be related to their higher education and occupation levels compared with seniors in the SU.VI.MAX study. Our analyses also confirm an association between smoking and less favorable diet, nutritional status, and PA summarized by lower scores (37).
Cohort studies with a long follow-up are necessary to identify the relationship between diet and development of chronic diseases. In the future, CVD, cancer, and mortality will be analyzed as separate outcomes in the SU.VI.MAX cohort due to continuing follow-up. In middle-aged men, healthy diet and lifestyle were related to a reduction in major chronic disease incidence after an 8-y follow-up. These results demonstrate the potential for improving the health status of the French population, particularly that of men, when PNNS nutritional guidelines are followed by changes in habits. They also support the validity of pursuing public health nutrition programs such as the PNNS.
| FOOTNOTES |
|---|
2 Author disclosures: C. Estaquio, K. Castetbon, E. Kesse-Guyot, S. Bertrais, V. Deschamps, L. Dauchet, S. Péneau, P. Galan, and S. Hercberg, no conflicts of interest. ![]()
3 Supplemental Table 1 is available with the online posting of this paper at jn.nutrition.org. ![]()
7 Abbreviations used: Apo, apoprotein; BMR, basal metabolic rate; BP, blood pressure; CVD, cardiovascular disease; EI, energy intake; F&V, fruit and vegetable; FSIPO, French score of indicators of the PNNS objectives; HEI, Healthy Eating Index; HR, hazard ratio; ICD-10-CM, International Classification of Diseases, 10th Revision, Clinical Modification; PA, physical activity; PNNS, Programme National Nutrition Santé; RDA, recommended dietary allowance; SBP, systolic blood pressure; SU.VI.MAX, Supplémentation en Vitamines et Minéraux AntioXydants. ![]()
Manuscript received 15 October 2007. Initial review completed 13 November 2007. Revision accepted 27 February 2008.
| LITERATURE CITED |
|---|
|
|
|---|
1. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.
2. COMA Working Group on Diet and Cancer. Nutritional aspects of the development of cancer. UK Department of Health Report on Health and Social Subjects No. 48. Norwich: HMSO; 1998.
3. WHO. Diet, Nutrition and the prevention of chronic diseases. Technical report series 916. Geneva: WHO; 2003.
4. Kant AK. Indexes of overall diet quality: a review. J Am Diet Assoc. 1996;96:785–91.[Medline]
5. Kant AK. Dietary patterns and health outcomes. J Am Diet Assoc. 2004;104:615–35.[Medline]
6. Waijers PM, Feskens EJ, Ocke MC. A critical review of predefined diet quality scores. Br J Nutr. 2007;97:219–31.[Medline]
7. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348:2599–608.
8. Huijbregts P, Feskens E, Rasanen L, Fidanza F, Nissinen A, Menotti A, Kromhout D. Dietary pattern and 20 year mortality in elderly men in Finland, Italy, and The Netherlands: longitudinal cohort study. BMJ. 1997;315:13–7.
9. Kant AK, Schatzkin A, Graubard BI, Schairer C. A prospective study of diet quality and mortality in women. JAMA. 2000;283:2109–15.
10. McCullough ML, Feskanich D, Rimm EB, Giovannucci EL, Ascherio A, Variyam JN, Spiegelman D, Stampfer MJ, Willett WC. Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in men. Am J Clin Nutr. 2000;72:1223–31.
11. McCullough ML, Feskanich D, Stampfer MJ, Rosner BA, Hu FB, Hunter DJ, Variyam JN, Colditz GA, Willett WC. Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in women. Am J Clin Nutr. 2000;72:1214–22.
12. McCullough ML, Feskanich D, Stampfer MJ, Giovannucci EL, Rimm EB, Hu FB, Spiegelman D, Hunter DJ, Colditz GA, et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr. 2002;76:1261–71.
13. McCullough ML, Willett WC. Evaluating adherence to recommended diets in adults: the Alternate Healthy Eating Index. Public Health Nutr. 2006;9:152–7.[Medline]
14. Harnack L, Nicodemus K, Jacobs DR Jr, Folsom AR. An evaluation of the Dietary Guidelines for Americans in relation to cancer occurrence. Am J Clin Nutr. 2002;76:889–96.
15. Hercberg S, Chat-Young S, Chauliac M. The French National Nutrition and Health Program: 2001–2006–2010. Int. J Public Health In press 2008.
16. Hercberg S, Preziosi P, Briancon S, Galan P, Triol I, Malvy D, Roussel AM, Favier A. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study: design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clin Trials. 1998;19:336–51.[Medline]
17. Le Moullec N, Deheeger M, Preziosi P, Montero P, Valeix P, Rolland-Cachera M-F, Potier de Courcy G, Christides J-P, Galan P, et al. Validation du manuel-photos utilisé pour l'enquête alimentaire de l'étude SU.VI.MAX. Cah Nutr Diet. 1996;31:158–64.
18. Hercberg S, editor. Table de composition des aliments SU.VI.MAX. Paris: Economica; 2005.
19. Vuillemin A, Oppert JM, Guillemin F, Essermeant L, Fontvieille AM, Galan P, Kriska AM, Hercberg S. Self-administered questionnaire compared with interview to assess past-year physical activity. Med Sci Sports Exerc. 2000;32:1119–24.[Medline]
20. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, Paffenbarger RS Jr. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25:71–80.[Medline]
21. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DR Jr, Schmitz KH, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32:S498–504.[Medline]
22. Galan P, Favier A, Preziosi P, Bertrais S, Arnault N, Hercberg S. The bank of biological material in the SU.VI.MAX study. Rev Epidemiol Sante Publique. 2003;51:147–50.[Medline]
23. Martin A, editor. Apports nutritionnels conseillés pour la population française. Tec et Doc. Paris, France; 2001.
24. Beer-Borst S, Hercberg S, Morabia A, Bernstein MS, Galan P, Galasso R, Giampaoli S, McCrum E, Panico S, et al. Dietary patterns in six European populations: results from EURALIM, a collaborative European data harmonization and information campaign. Eur J Clin Nutr. 2000;54:253–62.[Medline]
25. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr. 1985;39 Suppl 1:5–41.[Medline]
26. Report of a Joint FAO/WHO/UNU Expert Consultation. Energy and protein requirements. Technical report series 724. Geneva: WHO; 1985.
27. WHO. International classification of diseases, 10th revision clinical modification. Geneva: WHO; 2003.
28. Cox DR. Regression models and life tables (with discussion). R Stat Soc B. 1972;187–220.
29. Seymour JD, Calle EE, Flagg EW, Coates RJ, Ford ES, Thun MJ. Diet Quality Index as a predictor of short-term mortality in the American Cancer Society Cancer Prevention Study II Nutrition Cohort. Am J Epidemiol. 2003;157:980–8.
30. Kennedy ET, Ohls J, Carlson S, Fleming K. The Healthy Eating Index: design and applications. J Am Diet Assoc. 1995;95:1103–8.[Medline]
31. Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004;7:187–200.[Medline]
32. Gonzalez CA, Riboli E. Diet and cancer prevention: where we are, where we are going. Nutr Cancer. 2006;56:225–31.[Medline]
33. Fogli-Cawley JJ, Dwyer JT, Saltzman E, McCullough ML, Troy LM, Jacques PF. The 2005 Dietary Guidelines for Americans Adherence Index: development and application. J Nutr. 2006;136:2908–15.
34. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004;164:2335–42.
35. Sempos CT, Johnson NE, Smith EL, Gilligan C. Effects of intraindividual and interindividual variation in repeated dietary records. Am J Epidemiol. 1985;121:120–30.
36. Patterson RE, Haines PS, Popkin BM. Diet quality index: capturing a multidimensional behavior. J Am Diet Assoc. 1994;94:57–64.[Medline]
37. Dallongeville J, Marecaux N, Fruchart JC, Amouyel P. Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr. 1998;128:1450–7.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||